Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. OcluMed LLC
WARNING LETTER
•OcluMed LLC•September 12, 2023

OcluMed LLC – FDA Warning Letter, Sep 12, 2023

Record Details

The FDA issued a Warning Letter to AgentOf LLC (OcluMed LLC) following a July 2023 review of their website, oclumed.com. The FDA determined that the "OcluMed Nutritional/Lubricant Eye Drops" offered for sale are an unapproved new drug under section 505(a) of the FD&C Act (21 U.S.C. 355(a)). The introduction or delivery of this product into interstate commerce is a violation of sections 301(d) and 505(a) (21 U.S.C. 331(d) and 355(a)). The product is classified as a drug under section 201(g)(1) due to therapeutic claims on the website, including reversing cataracts and improving vision for macular degeneration. Since the product is not generally recognized as safe and effective (GRASE) for its intended uses, it is considered a "new drug" under section 201(p) of the FD&C Act, requiring an approved FDA application, which OcluMed Eye Drops lacks. The FDA highlighted the public health risk associated with unapproved ophthalmic products. AgentOf LLC must respond within fifteen working days, detailing corrective actions, steps to prevent recurrence, and supporting documentation. Failure to comply may lead to legal actions such as seizure and injunction.

Company
OcluMed LLC
Inspection date
September 12, 2023
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Jill P. Furman (Director)
View Company Profile

ID · 68b44390-6155-4501-86cb-e04b74f30d82

Violation Codes4
21.U.S.C. 355(a)21 U.S.C. 331(d)21 U.S.C. 321(g)(1)21 U.S.C. 321(p)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore OcluMed LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.